1. Home
  2. ATEC vs NRIX Comparison

ATEC vs NRIX Comparison

Compare ATEC & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

HOLD

Current Price

$10.35

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$16.96

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEC
NRIX
Founded
1990
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ATEC
NRIX
Price
$10.35
$16.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
12
Target Price
$22.00
$30.50
AVG Volume (30 Days)
2.3M
986.4K
Earning Date
05-05-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
15.04
N/A
EPS
N/A
N/A
Revenue
$101,739,000.00
$76,987,000.00
Revenue This Year
$18.97
N/A
Revenue Next Year
$16.70
$48.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
99.31
52 Week Low
$9.11
$8.20
52 Week High
$23.29
$22.50

Technical Indicators

Market Signals
Indicator
ATEC
NRIX
Relative Strength Index (RSI) 45.05 56.43
Support Level N/A $16.02
Resistance Level $16.22 $17.68
Average True Range (ATR) 0.69 0.70
MACD 0.01 -0.00
Stochastic Oscillator 46.63 48.65

Price Performance

Historical Comparison
ATEC
NRIX

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: